Celldex Therapeutics, Inc. (NASDAQ:CLDX)

CAPS Rating: 3 out of 5

A biopharmaceutical company engaged in the discovery, development and commercialization of products that harness the human immune response to prevent and treat disease.

Recs

0
Player Avatar portefeuille (99.65) Submitted: 12/18/2012 10:51:51 PM : Outperform Start Price: $6.17 CLDX Score: +163.58

http://caps.fool.com/Blogs/fund-trades/779590.
http://twitter.com/portefeuillefun.

Featured Broker Partners


Advertisement